The campaign for rituximab in Iraq
Al-Hayat Association in Iraq has successfully lobbied the Ministry of Health to provide better access to the MS treatment, rituximab. The campaign is part of the organisation’s aim to secure a range of treatments for people with MS in Iraq. Learn more about their campaign success.
Research highlights of 2016
Professor Alan Thompson highlights some of 2016’s research discoveries in MS